No black box warning on record for Quinapril

As of the latest FDA labeling reviewed, Quinapril (QUINAPRIL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Quinapril medicine page for the complete safety profile.

Other warnings & precautions

WARNING: FETAL TOXICITY • When pregnancy is detected, discontinue quinapril as soon as possible. • Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. See Warnings: Fetal Toxicity
WARNINGS Anaphylactoid and Possibly Related Reactions Presumably because ACE inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including quinapril) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema : Angioedema of the face, extremities, lips, tongue, glottis, and laryn

No black box warning on record for Quinapril

Other warnings & precautions

WARNING: FETAL TOXICITY • When pregnancy is detected, discontinue quinapril as soon as possible. • Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. See Warnings: Fetal Toxicity
WARNINGS Anaphylactoid and Possibly Related Reactions Presumably because ACE inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including quinapril) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema : Angioedema of the face, extremities, lips, tongue, glottis, and laryn

Quinapril Black Box Warning

No black box warning on record for Quinapril

Other warnings & precautions

Quinapril Black Box Warning

No black box warning on record for Quinapril

Other warnings & precautions